Deep Tech Startups

TideWise develops autonomous marine robotics systems, including unmanned surface vehicles (USVs) and drones, for hydrographic and geophysical surveys, offshore and coastal logistics, and environmental monitoring. It designs solutions in-house to meet client needs while reducing operational costs, human risk, and CO2 emissions.

1 investor

Timegate provides real-time process analytics tools for biopharmaceutical manufacturing using patented Timegated Raman Technology, which enables rapid spectral analysis of bioprocesses without fluorescence interference. The company serves biopharmaceutical manufacturers seeking quality control and process monitoring solutions.

1 investor

TimeLab builds scientifically validated operational decision support software, using AI-driven systems and near-future state assessments to improve dispatch and fleet deployment for emergency services. Spun out of the Dutch National Mathematics Research Institute (CWI) in 2016, it develops products for emergency dispatch and ambulance management.

1 investor

A venture capital firm that invests in the commercialization of research, with a focus on innovations emerging from the University of Melbourne and its affiliated medical research institutions and hospitals in the Melbourne Biomedical Precinct.

1 investor

The Tiny Cargo Co. isolates milk-derived exosomes from cow's milk at industrial scale and loads them with therapeutic cargoes such as peptides, RNAs, and biologics for oral drug delivery. It serves pharmaceutical partners developing therapeutics and is advancing XOlacta, a milk-exosome drug loaded with the aCT11 peptide as a cardioprotectant and radioprotectant.

1 investor

Tenna delivers real-time spectrum intelligence for defense and autonomous systems operators by detecting, classifying, and geolocating radio frequency interference using AI-powered analysis of global sensor data. The company serves the U.S. Department of Defense, allied militaries, and operators of advanced autonomous systems with software-only solutions that integrate into existing hardware infrastructure.

1 investor

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer. Its approach aims to increase specificity, reduce toxicity, and limit drug resistance in oncology treatments.

1 investor

Tipply develops causal world models and AI systems that control flight systems, enabling aircraft to make autonomous, dynamics-driven decisions. Its technology targets airborne autonomy tasks such as target tracking, station-keeping, long-range navigation, and high-altitude flight, including stratospheric applications.

1 investor

Tissue Dynamics operates a drug discovery platform that uses real-time sensors, robotic automation, and AI software to grow and monitor human organoids at scale, generating human-relevant data on drug safety, efficacy, and toxicity. It serves pharmaceutical and biotech partners with compound profiling, screening, and target identification to de-risk and accelerate drug development.

1 investor

Titanium Technology develops an electrochemical anti-biofouling system for titanium surfaces used in marine cooling systems and industrial applications, preventing organism adhesion without biocides or environmental impact. The company licenses its technology to industries affected by biofouling, including naval, industrial, and hospitality sectors.

1 investor

TiVentures is a seed-stage venture capital fund, owned by the Fondazione Centenario BancaStato, that invests in early-stage technology companies based in southern Switzerland (Ticino). It focuses on the life science, medical, high-tech, and IT sectors.

1 investor

Tobii is a global leader in eye tracking and attention computing technology that serves research institutions, automotive manufacturers, medical device makers, XR headset developers, and consumer brands. The company develops wearable trackers, screen-based solutions, and embedded integrations that measure human attention for applications ranging from driver monitoring systems to human-machine interaction enhancement.

1 investor

Tokoshie develops AI-CAD software and 3D printer infrastructure to enable anyone to create, lowering barriers to digital fabrication and design.

1 investor

Tokyo AI provides edge AI solutions for industrial and infrastructure applications, combining real-time processing with low power consumption. The company delivers end-to-end AI implementations for railways, infrastructure, and manufacturing sectors.

1 investor

Tonari develops hardware and software to create life-sized portals that enable remote presence and connection across physical locations. The company serves organizations seeking to bridge distance for collaborative work, education, and community engagement.

1 investor

Tonk builds a portable data layer and memory primitives for shared, queryable knowledge, including a persistent memory layer called carry. It develops open infrastructure intended to let people and their tools store and access structured data collaboratively.

1 investor

Tools for Humanity develops technology intended for people in the AI era, employing scientists, engineers, economists and creatives. It is a technology company operating out of the United States and Germany.

1 investor

Topological develops physics-based foundation models for CAD optimization to help hardware engineering teams accelerate their design and optimization workflows. The platform generates efficient designs for complex mechanical problems by understanding physics, geometry, and manufacturability constraints.

1 investor

Topos Bio develops an AI-native drug discovery platform focused on intrinsically disordered proteins, which are dynamic proteins associated with diseases such as Alzheimer's and prostate cancer. Its approach models protein ensembles instead of single static structures to target proteins previously considered undruggable.

1 investor

Toposware is a research and engineering company developing cryptographic infrastructure and protocol standards for decentralized systems. The company focuses on advancing distributed systems and open internet standards.

1 investor

Toralgen is a preclinical biopharmaceutical company developing oral drug delivery treatments for diabetes and autoimmune disorders using a poly-bile nanoparticle platform technology licensed from Yale University research.

1 investor

Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.

1 investor

Torr FoodTech develops proprietary technology to create a new generation of healthy snacks. The company positions itself within the food technology and snack products industry.

1 investor

Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.

1 investor